These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 3038405)

  • 1. Tissue converting enzyme inhibition and cardiovascular effects of converting enzyme inhibitors.
    Unger T; Schölkens BA; Ganten D; Lang RE
    Clin Exp Hypertens A; 1987; 9(2-3):417-26. PubMed ID: 3038405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of converting enzyme inhibitors on tissue converting enzyme and angiotensin II: therapeutic implications.
    Unger T; Ganten D; Lang RE
    Am J Cardiol; 1987 Apr; 59(10):18D-22D. PubMed ID: 3034027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue converting enzyme and cardiovascular actions of converting enzyme inhibitors.
    Unger T; Ganten D; Lang RE
    J Cardiovasc Pharmacol; 1986; 8 Suppl 10():S75-81. PubMed ID: 2438496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue renin-angiotensin systems in the heart and vasculature: possible involvement in the cardiovascular actions of converting enzyme inhibitors.
    Unger T; Gohlke P
    Am J Cardiol; 1990 May; 65(19):3I-10I. PubMed ID: 2159693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is tissue converting enzyme inhibition a determinant of the antihypertensive efficacy of converting enzyme inhibitors? Studies with the two different compounds, Hoe498 and MK421, in spontaneously hypertensive rats.
    Unger T; Ganten D; Lang RE; Schölkens BA
    J Cardiovasc Pharmacol; 1984; 6(5):872-80. PubMed ID: 6209494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistent tissue converting enzyme inhibition following chronic treatment with Hoe498 and MK421 in spontaneously hypertensive rats.
    Unger T; Ganten D; Lang RE; Schölkens BA
    J Cardiovasc Pharmacol; 1985; 7(1):36-41. PubMed ID: 2580148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antihypertensive action and inhibition of tissue converting enzyme (CE) by three prodrug CE inhibitors, enalapril, ramipril and perindopril in stroke-prone spontaneously hypertensive rats.
    Moursi MG; Ganten D; Lang RE; Unger T
    J Hypertens Suppl; 1986 Oct; 4(3):S495-8. PubMed ID: 3023591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of converting enzyme in brain tissue and cerebrospinal fluid of rats following chronic oral treatment with the converting enzyme inhibitors ramipril and Hoe 288.
    Gohlke P; Schölkens B; Henning R; Urbach H; Unger T
    J Cardiovasc Pharmacol; 1989; 14 Suppl 4():S32-6. PubMed ID: 2483426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of an angiotensin-converting enzyme (ACE) inhibitor, SA446, on tissue ACE activity in normotensive, spontaneously hypertensive, and renal hypertensive rats.
    Nakata K; Nishimura K; Takada T; Ikuse T; Yamauchi H; Iso T
    J Cardiovasc Pharmacol; 1987 Mar; 9(3):305-10. PubMed ID: 2437397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2-[N-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L-alanyl]-(1S,3S,5S)-2- azabicyclo[3.3.0]octane-3-carboxylic acid (Hoe 498): antihypertensive action and persistent inhibition of tissue converting enzyme activity in spontaneously hypertensive rats.
    Unger T; Fleck T; Ganten D; Lang RE; Rettig F
    Arzneimittelforschung; 1984; 34(10B):1426-30. PubMed ID: 6097269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beneficial effects of the converting enzyme inhibitor, ramipril, in ischemic rat hearts.
    Linz W; Schölkens BA; Han YF
    J Cardiovasc Pharmacol; 1986; 8 Suppl 10():S91-9. PubMed ID: 2438498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin-converting enzyme in renal and cerebral tissue and implications for successful blood pressure management.
    Reams GP
    Am J Cardiol; 1992 Apr; 69(10):59C-64C. PubMed ID: 1312296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of tissue angiotensin converting enzyme activity prevents malignant hypertension in TGR(mREN2)27.
    Montgomery HE; Kiernan LA; Whitworth CE; Fleming S; Unger T; Gohlke P; Mullins JJ; McEwan JR
    J Hypertens; 1998 May; 16(5):635-43. PubMed ID: 9797175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute and chronic in vivo inhibition of angiotensin-converting enzyme by perindopril in the endothelium and adventitia of large arteries and organs of the rabbit.
    Zhuo J; Casley D; Murone C; Mendelsohn FA
    J Cardiovasc Pharmacol; 1997 Mar; 29(3):297-310. PubMed ID: 9125666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antihypertensive action and inhibition of tissue conversion enzyme by ramipril, perindopril and enalapril in the spontaneously hypertensive rat (SHRSP)].
    Unger T; Moursi MG; Lebrun C; Ganten D; Lang RE
    Arch Mal Coeur Vaiss; 1986 Jun; 79(6):971-4. PubMed ID: 3026275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Converting enzyme inhibitors and their effects on the renin-angiotensin system of the blood vessel wall.
    Unger T; Gohlke P; Ganten D; Lang RE
    J Cardiovasc Pharmacol; 1989; 13 Suppl 3():S8-16. PubMed ID: 2474111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antihypertensive action of the converting enzyme inhibitor perindopril (S9490-3) in spontaneously hypertensive rats: comparison with enalapril (MK421) and ramipril (Hoe498).
    Unger T; Moursi M; Ganten D; Hermann K; Lang RE
    J Cardiovasc Pharmacol; 1986; 8(2):276-85. PubMed ID: 2422465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue renin-angiotensin systems and their modulation: the heart as a paradigm for new aspects of converting enzyme inhibition.
    Lindpaintner K; Ganten D
    Cardiology; 1991; 79 Suppl 1():32-44. PubMed ID: 1655263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular actions and tissue-converting enzyme inhibitory effects of chronic enalapril and trandolapril treatment of spontaneously hypertensive rats.
    Chevillard C; Brown NL; Jouquey S; Mathieu MN; Laliberté F; Hamon G
    J Cardiovasc Pharmacol; 1989 Aug; 14(2):297-301. PubMed ID: 2476605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of oral trandolapril and enalapril on rat tissue angiotensin-converting enzyme.
    Chevillard C; Brown NL; Mathieu MN; Laliberté F; Worcel M
    Eur J Pharmacol; 1988 Feb; 147(1):23-8. PubMed ID: 2836219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.